Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Journal of Clinical Pharmacy and Therapeutics|September 15, 2012
Do we need authorized orphan drugs when compounded medications are available?M Dooms, H Pincé, S SimoensJournal of Clinical Pharmacy and Therapeutics|May 7, 2011
How much is the life of a cancer patient worth? A pharmaco-economic perspectiveS Simoens, M DoomsInternational Journal of Bio-Medical Computing|April 1, 1990
Computer aided interpretation of acid-base disordersH Pincé, R Verberckmoes, J L WillemsJournal of Clinical Pharmacy and Therapeutics|December 21, 2006
Using the Delphi technique in economic evaluation: time to revisit the oracle?S SimoensJournal of Clinical Pharmacy and Therapeutics|August 5, 2011
What is the value for money of medicines? A registry studyS SimoensAllergy|July 7, 2012
The cost-effectiveness of immunotherapy for respiratory allergy: a reviewS SimoensOrphanet Journal of Rare Diseases|June 8, 2023
Pharmacists are initiators in palliative care for patients with rare diseasesM DoomsOrphanet Journal of Rare Diseases|March 5, 2016
Orphan devices: yesterday is history; tomorrow is mystery: towards a European orphan device directive?Marc M DoomsOrphanet Journal of Rare Diseases|December 23, 2015
Rare diseases and orphan drugs: 500 years agoMarc M DoomsPageof 5